StockData
Q/C Technologies, Inc. logo

Q/C Technologies, Inc. (QCLS) stock

QCLSNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.33+0.01 (+4.05%)

Close on Nov 17, 2026Market cap $2.74MP/E –Yield –

Q/C Technologies enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Q/C Technologies's enterprise value was -$8.21M on Nov 11, 2026, against $664.11K a year earlier. Over the last 5 years it ranged from -$8.40M to $5.42B, with a median of $12.90M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$8.21M-535.6%
2025Dec 31, 2025$1.88M–
2024Dec 31, 2024-$7.71M-102.1%
2023Dec 29, 2023$367.62M-73.7%
2022Dec 30, 2022$1.40B-57.6%
2021Dec 31, 2021$3.29B+208.4%
2020Dec 31, 2020$1.07B+898.5%
2019Dec 31, 2019$106.91M-87.7%
2018Dec 31, 2018$872.05M+1024.9%
2017Dec 29, 2017$77.52M-88.6%
2016Dec 30, 2016$682.12M+68.2%
2015Dec 31, 2015$405.58M-68.7%
2014Dec 31, 2014$1.29B–

More Q/C Technologies figures

See a number that looks wrong?